» Articles » PMID: 31702856

Discovery of a Cryptic Intermediate in Late Steps of Mithramycin Biosynthesis

Overview
Specialty Chemistry
Date 2019 Nov 9
PMID 31702856
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

MtmOIV and MtmW catalyze the final two reactions in the mithramycin (MTM) biosynthetic pathway, the Baeyer-Villiger opening of the fourth ring of premithramycin B (PMB), creating the C3 pentyl side chain, strictly followed by reduction of the distal keto group on the new side chain. Unexpectedly this results in a C2 stereoisomer of mithramycin, iso-mithramycin (iso-MTM). Iso-MTM undergoes a non-enzymatic isomerization to MTM catalyzed by Mg ions. Crystal structures of MtmW and its complexes with co-substrate NADPH and PEG, suggest a catalytic mechanism of MtmW. The structures also show that a tetrameric assembly of this enzyme strikingly resembles the ring-shaped β subunit of a vertebrate ion channel. We show that MtmW and MtmOIV form a complex in the presence of PMB and NADPH, presumably to hand over the unstable MtmOIV product to MtmW, yielding iso-MTM, as a potential self-resistance mechanism against MTM toxicity.

Citing Articles

A three-level regulatory mechanism of the aldo-keto reductase subfamily AKR12D.

Xiao Z, Zha J, Yang X, Huang T, Huang S, Liu Q Nat Commun. 2024; 15(1):2128.

PMID: 38459030 PMC: 10923870. DOI: 10.1038/s41467-024-46363-z.

References
1.
Hou C, Rohr J, Parkin S, Tsodikov O . How mithramycin stereochemistry dictates its structure and DNA binding function. Medchemcomm. 2019; 10(5):735-741. PMC: 6533888. DOI: 10.1039/c9md00100j. View

2.
Steffensky M, Muhlenweg A, Wang Z, Li S, Heide L . Identification of the novobiocin biosynthetic gene cluster of Streptomyces spheroides NCIB 11891. Antimicrob Agents Chemother. 2000; 44(5):1214-22. PMC: 89847. DOI: 10.1128/AAC.44.5.1214-1222.2000. View

3.
Gibson M, Nur-E-Alam M, Lipata F, Oliveira M, Rohr J . Characterization of kinetics and products of the Baeyer-Villiger oxygenase MtmOIV, the key enzyme of the biosynthetic pathway toward the natural product anticancer drug mithramycin from Streptomyces argillaceus. J Am Chem Soc. 2005; 127(50):17594-5. DOI: 10.1021/ja055750t. View

4.
Remsing L, Gonzalez A, Nur-E-Alam M, Fernandez-Lozano M, Brana A, Rix U . Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK: three new products generated in the mithramycin producer Streptomyces argillaceus through combinatorial biosynthesis. J Am Chem Soc. 2003; 125(19):5745-53. PMC: 4480629. DOI: 10.1021/ja034162h. View

5.
Weidenbach S, Hou C, Chen J, Tsodikov O, Rohr J . Dimerization and DNA recognition rules of mithramycin and its analogues. J Inorg Biochem. 2016; 156:40-7. PMC: 4874495. DOI: 10.1016/j.jinorgbio.2015.12.011. View